Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

403 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial.
Tomita N, Ishiyama H, Makita C, Ohshima Y, Nagai A, Baba F, Kuno M, Otsuka S, Kondo T, Sugie C, Kawai T, Takaoka T, Okazaki D, Torii A, Niwa M, Kita N, Takano S, Kawakami S, Matsuo M, Kumano T, Ito M, Adachi S, Abe S, Murao T, Hiwatashi A. Tomita N, et al. Among authors: kuno m. BMC Cancer. 2022 Dec 5;22(1):1259. doi: 10.1186/s12885-022-10371-3. BMC Cancer. 2022. PMID: 36471274 Free PMC article.
Clinical Outcomes of Radiation Therapy for Angiosarcoma of the Scalp and Face: A Multi-Institutional Observational Study.
Niwa M, Tomita N, Takaoka T, Takano H, Makita C, Matsuo M, Adachi S, Oshima Y, Yamamoto S, Kuno M, Miyakawa A, Okazaki D, Torii A, Kita N, Takano S, Nakamura M, Kato H, Morita A, Hiwatashi A. Niwa M, et al. Among authors: kuno m. Cancers (Basel). 2023 Jul 20;15(14):3696. doi: 10.3390/cancers15143696. Cancers (Basel). 2023. PMID: 37509356 Free PMC article.
Simultaneous boost radiotherapy versus conventional dose radiotherapy for patients with newly diagnosed glioblastoma: a multi-institutional analysis.
Takano S, Tomita N, Kuno M, Niwa M, Torii A, Takaoka T, Kita N, Okazaki D, Yamamoto S, Kawai T, Sugie C, Ogawa Y, Matsumoto K, Uchiyama K, Otsuka S, Matsui T, Miyakawa A, Mizuno T, Iida M, Tanikawa M, Mase M, Hiwatashi A. Takano S, et al. Among authors: kuno m. Sci Rep. 2024 Apr 23;14(1):9283. doi: 10.1038/s41598-024-60154-y. Sci Rep. 2024. PMID: 38654028 Free PMC article.
Salvage radiotherapy for locoregional recurrence of esophageal cancer after surgery.
Torii A, Tomita N, Takaoka T, Kondo T, Yamamoto S, Sugie C, Nagai A, Miyakawa A, Kuno M, Uchiyama K, Otsuka S, Ogawa Y, Takano S, Kita N, Tanaka T, Ogawa R, Kubota E, Takiguchi S, Kataoka H, Hiwatashi A. Torii A, et al. Among authors: kuno m. Jpn J Clin Oncol. 2025 Jan 8;55(1):59-66. doi: 10.1093/jjco/hyae124. Jpn J Clin Oncol. 2025. PMID: 39239699
Neutrophil‑to‑lymphocyte ratio and risk of disease progression in patients with nivolumab‑treated unresectable or recurrent gastric cancer.
Hayashi H, Yasufuku I, Sato Y, Fujibayashi S, Chikaishi W, Endo M, Horaguchi T, Yokoi R, Matsumoto K, Kuno M, Sengoku Y, Fukada M, Asai R, Tajima JY, Makiyama A, Kiyama S, Tanaka Y, Murase K, Ishihara T, Matsuhashi N. Hayashi H, et al. Among authors: kuno m. Oncol Lett. 2024 Oct 22;29(1):20. doi: 10.3892/ol.2024.14766. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39492934 Free PMC article.
403 results